|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/37 | (2006.01) |
| C12N 15/00 | (2006.01) | ||
| C12P 21/08 | (2006.01) | ||
| C07K 14/755 | (2006.01) | ||
| C12N 15/62 | (2006.01) | ||
| A61K 38/36 | (2006.01) |
| (11) | Number of the document | 2882450 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13816031.2 |
| Date of filing the European patent application | 2013-07-10 | |
| (97) | Date of publication of the European application | 2015-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-27 |
| (46) | Date of publication of the claims translation | 2020-03-25 |
| (86) | Number | PCT/US2013/049989 |
| Date | 2013-07-10 |
| (87) | Number | WO 2014/011819 |
| Date | 2014-01-16 |
| (30) | Number | Date | Country code |
| 201261670401 P | 2012-07-11 | US | |
| 201361759819 P | 2013-02-01 | US | |
| 201361801504 P | 2013-03-15 | US | |
| 201361801544 P | 2013-03-15 | US | |
| 201361827158 P | 2013-05-24 | US | |
| 201361840811 P | 2013-06-28 | US |
| (72) |
CHHABRA, Ekta, Seth, US
LIU, Tongyao, US
CHANG, Pei-yun, US
PETERS, Robert, T., US
KULMAN, John, US
|
| (73) |
Bioverativ Therapeutics Inc.,
225 Second Avenue, Waltham, MA 02451,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Faktoriaus VIII komplekso su XTEN ir von Vilebrando faktoriumi baltymas ir jo panaudojimas |
| FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-06-04 | 13 | 289.00 EUR |
| 2026-07-10 |